These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
730 related articles for article (PubMed ID: 32951514)
21. Left atrial appendage closure followed by 6 weeks of antithrombotic therapy: a prospective single-center experience. Chun KR; Bordignon S; Urban V; Perrotta L; Dugo D; Fürnkranz A; Nowak B; Schmidt B Heart Rhythm; 2013 Dec; 10(12):1792-9. PubMed ID: 23973952 [TBL] [Abstract][Full Text] [Related]
22. Clinical outcomes of left atrial appendage occlusion versus direct oral anticoagulation in patients with atrial fibrillation and prior ischemic stroke: A propensity-score matched study. Korsholm K; Valentin JB; Damgaard D; Diener HC; Camm AJ; Landmesser U; Hildick-Smith D; Johnsen SP; Nielsen-Kudsk JE Int J Cardiol; 2022 Sep; 363():56-63. PubMed ID: 35780932 [TBL] [Abstract][Full Text] [Related]
23. Percutaneous Left Atrial Appendage Occlusion: An Emerging Option in Patients with Atrial Fibrillation at High Risk of Bleeding. Cimmino G; Loffredo FS; Gallinoro E; Prozzo D; Fabiani D; Cante L; Salerno G; Cappelli Bigazzi M; Golino P Medicina (Kaunas); 2021 May; 57(5):. PubMed ID: 34063719 [TBL] [Abstract][Full Text] [Related]
24. Left Atrial Appendage Occlusion Versus Oral Anticoagulation in Atrial Fibrillation : A Decision Analysis. Chew DS; Zhou K; Pokorney SD; Matchar DB; Vemulapalli S; Allen LA; Jackson KP; Samad Z; Patel MR; Freeman JV; Piccini JP Ann Intern Med; 2022 Sep; 175(9):1230-1239. PubMed ID: 35969865 [TBL] [Abstract][Full Text] [Related]
25. Percutaneous left atrial appendage occlusion and risk of stroke, hospitalized bleeding and death in Medicare beneficiaries. Wang W; Chen LY; Walker RF; Alonso A; Norby FL; Lakshminarayan K; Lutsey PL Pharmacoepidemiol Drug Saf; 2024 Apr; 33(4):e5786. PubMed ID: 38565524 [TBL] [Abstract][Full Text] [Related]
26. Non-vitamin K antagonist oral anticoagulation versus left atrial appendage occlusion for primary and secondary stroke prevention after cardioembolic stroke. Paiva L; Coelho J; Barra S; Costa M; Sargento-Freitas J; Cunha L; Gonçalves L Rev Port Cardiol (Engl Ed); 2021 May; 40(5):357-365. PubMed ID: 34187638 [TBL] [Abstract][Full Text] [Related]
27. Percutaneous left atrial appendage closure, a safe alternative to anticoagulation for patients with nonvalvular atrial fibrillation and end-stage renal disease on hemodialysis: A single center experience. Xipell M; Flores-Umanzor E; Ojeda R; Arias M; Cepas-Guillén PL; Regueiro A; Freixa X; Cases A; Maduell F Artif Organs; 2020 May; 44(5):513-521. PubMed ID: 31715006 [TBL] [Abstract][Full Text] [Related]
28. Safety and efficacy of the Amplatzer Amulet and Watchman 2.5 for left atrial appendage occlusion: A systematic review and meta-analysis. Zhu MZ; Song H; Song GM; Bai X Pacing Clin Electrophysiol; 2022 Oct; 45(10):1237-1247. PubMed ID: 35933600 [TBL] [Abstract][Full Text] [Related]
29. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. Holmes DR; Kar S; Price MJ; Whisenant B; Sievert H; Doshi SK; Huber K; Reddy VY J Am Coll Cardiol; 2014 Jul; 64(1):1-12. PubMed ID: 24998121 [TBL] [Abstract][Full Text] [Related]
30. Lower rate of major bleeding in very high risk patients undergoing left atrial appendage occlusion: A propensity score-matched comparison with direct oral anticoagulant. Magnocavallo M; Della Rocca DG; Vetta G; Mohanty S; Gianni C; Polselli M; Rossi P; Parlavecchio A; Fazia MV; Guarracini F; De Vuono F; Bisignani A; Pannone L; Raposeiras-Roubín S; Lochy S; Cauti FM; Burkhardt JD; Boveda S; Sarkozy A; Sorgente A; Bianchi S; Chierchia GB; de Asmundis C; Al-Ahmad A; Di Biase L; Horton RP; Natale A Heart Rhythm; 2024 Aug; 21(8):1267-1276. PubMed ID: 38246567 [TBL] [Abstract][Full Text] [Related]
31. Left atrial appendage closure-indications, techniques, and outcomes: results of the European Heart Rhythm Association Survey. Pison L; Potpara TS; Chen J; Larsen TB; Bongiorni MG; Blomström-Lundqvist C; Europace; 2015 Apr; 17(4):642-6. PubMed ID: 25833883 [TBL] [Abstract][Full Text] [Related]
32. Feasibility of Left Atrial Appendage Occlusion in Left Atrial Appendage Thrombus: A Systematic Review. Sharma SP; Cheng J; Turagam MK; Gopinathannair R; Horton R; Lam YY; Tarantini G; D'Amico G; Freixa Rofastes X; Lange M; Natale A; Lakkireddy DR JACC Clin Electrophysiol; 2020 Apr; 6(4):414-424. PubMed ID: 32327075 [TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness analysis of left atrial appendage occlusion in patients with atrial fibrillation and contraindication to oral anticoagulation. Labori F; Persson J; Bonander C; Jood K; Svensson M Eur Heart J; 2022 Mar; 43(13):1348-1356. PubMed ID: 34919652 [TBL] [Abstract][Full Text] [Related]
35. Left atrial appendage occlusion in high-risk patients with non-valvular atrial fibrillation. Berti S; Pastormerlo LE; Rezzaghi M; Trianni G; Paradossi U; Cerone E; Ravani M; De Caterina AR; Rizza A; Palmieri C Heart; 2016 Dec; 102(24):1969-1973. PubMed ID: 27492943 [TBL] [Abstract][Full Text] [Related]
36. Cost-effectiveness analysis of left atrial appendage occlusion compared with pharmacological strategies for stroke prevention in atrial fibrillation. Lee VW; Tsai RB; Chow IH; Yan BP; Kaya MG; Park JW; Lam YY BMC Cardiovasc Disord; 2016 Aug; 16(1):167. PubMed ID: 27581874 [TBL] [Abstract][Full Text] [Related]
38. Percutaneous left atrial appendage occlusion: A South African experience. Dippenaar AP; Saaiman JA; Brink PA; Heradien MJ; Van der Bijl P S Afr Med J; 2022 Apr; 112(4):268-272. PubMed ID: 35587805 [TBL] [Abstract][Full Text] [Related]
39. Indications for percutaneous left atrial appendage occlusion in hospitalized patients with atrial fibrillation. Vrana E; Kartas A; Samaras A; Vasdeki D; Forozidou E; Liampas E; Karvounis H; Giannakoulas G; Tzikas A J Cardiovasc Med (Hagerstown); 2022 Mar; 23(3):176-182. PubMed ID: 34580251 [TBL] [Abstract][Full Text] [Related]
40. Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage. Boersma LV; Ince H; Kische S; Pokushalov E; Schmitz T; Schmidt B; Gori T; Meincke F; Protopopov AV; Betts T; Mazzone P; Foley D; Grygier M; Sievert H; De Potter T; Vireca E; Stein K; Bergmann MW; Circ Arrhythm Electrophysiol; 2019 Apr; 12(4):e006841. PubMed ID: 30939908 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]